Enzymatica is hoping to shake up the OTC cold and flu category across North America and Asia by introducing its virus-blocking mouth spray ColdZyme.
Enzymatica Plots Entry To North America And Asia
The Swedish firm is plotting the path towards launching its ColdZyme virus-blocking spray in China and Japan, while efforts are also underway to find a partner for the North American market.
